Valion Bio, Inc.
VBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787740
No open-market purchases or sales by Valion Bio, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $205.6K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Valion Bio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +5 vs. Q4 2022
- Shares held
- 1.43M
- +1.36M (+2,005.1%) vs. Q4 2022
- Total value
- $215.6K
- +$172.2K (+396.9%) vs. Q4 2022
- New holders
- 8
- 2 more added
- Sold out
- 3
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $205.6K |
| Q1 2026 | 9 | $233.4K |
| Q4 2025 | 7 | $118.8K |
| Q3 2025 | 7 | $567.1K |
| Q2 2025 | 4 | $186.6K |
| Q1 2025 | 2 | $54 |
| Q4 2024 | 9 | $90.7K |
| Q3 2024 | 10 | $69.8K |
| Q2 2024 | 10 | $240.6K |
| Q1 2024 | 5 | $83.8K |
| Q4 2023 | 7 | $112.0K |
| Q3 2023 | 6 | $31.7K |
| Q2 2023 | 12 | $96.3K |
| Q1 2023 | 12 | $215.6K |
| Q4 2022 | 7 | $43.4K |
| Q3 2022 | 4 | $30.0K |
| Q2 2022 | 5 | $104.0K |
| Q1 2022 | 7 | $329.0K |
| Q4 2021 | 9 | $492.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Valion Bio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 46 | $7 | 0.00% | +1+2.2% | Added |
| Goldman Sachs Group Inc | 10,413 | $1.57K | 0.00% | +10,413 | New |
| Susquehanna International Group, LLP | 12,787 | $1.93K | 0.00% | +12,787 | New |
| Tower Research Capital LLC (TRC) | 11,075 | $2.00K | 0.00% | −25−0.2% | Reduced |
| Advisor Group Holdings, Inc. | 14,600 | $2.20K | 0.00% | 00.0% | Unchanged |
| One68 Global Capital, LLC | 19,100 | $2.88K | 0.00% | +19,100 | New |
| HRT Financial LP | 27,042 | $4.00K | 0.00% | +27,042 | New |
| Ergoteles LLC | 28,403 | $4.28K | 0.00% | +28,403 | New |
| Boothbay Fund Management, LLC | 30,000 | $4.52K | 0.00% | +30,000 | New |
| UBS Group AG | 132,860 | $20.1K | 0.00% | +129,269+3,599.8% | Added |
| Warberg Asset Management LLC | 541,618 | $81.6K | 0.02% | +541,618 | New |
| Sheets Smith Wealth Management | 600,000 | $90.6K | 0.01% | +600,000 | New |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −25,900−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,585−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −12−100.0% | Sold out |